BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
News | 03. 19. 2013
Art Pappas joins a panel at the 2013 BIO International Convention in Chicago titled, "Money Ball - Winning Venture Strategies."
